Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine, Nashville, Tennessee, United States of America.
Department of Microbiology and Immunology, Meharry Medical College School of Medicine, Nashville, Tennessee, United States of America.
PLoS One. 2021 Mar 9;16(3):e0246393. doi: 10.1371/journal.pone.0246393. eCollection 2021.
Evidence link bacterial enterotoxins to apparent crypt-cell like cells (CCLCs), and Alpha Defensin 5 (DEFA5) expansion in the colonic mucosa of Crohn's colitis disease (CC) patients. These areas of ectopic ileal metaplasia, positive for Paneth cell (PC) markers are consistent with diagnosis of CC. Retrospectively, we: 1. Identified 21 patients with indeterminate colitis (IC) between 2000-2007 and were reevaluation their final clinical diagnosis in 2014 after a followed-up for mean 8.7±3.7 (range, 4-14) years. Their initial biopsies were analyzed by DEFA5 bioassay. 2. Differentiated ulcer-associated cell lineage (UACL) analysis by immunohistochemistry (IHC) of the CC patients, stained for Mucin 6 (MUC6) and DEFA5. 3. Treated human immortalized colonic epithelial cells (NCM460) and colonoids with pure DEFA5 on the secretion of signatures after 24hr. The control colonoids were not treated. 4. Treated colonoids with/without enterotoxins for 14 days and the spent medium were collected and determined by quantitative expression of DEFA5, CCLCs and other biologic signatures. The experiments were repeated twice. Three statistical methods were used: (i) Univariate analysis; (ii) LASSO; and (iii) Elastic net. DEFA5 bioassay discriminated CC and ulcerative colitis (UC) in a cohort of IC patients with accuracy. A fit logistic model with group CC and UC as the outcome and the DEFA5 as independent variable differentiator with a positive predictive value of 96 percent. IHC staining of CC for MUC6 and DEFA5 stained in different locations indicating that DEFA5 is not co-expressed in UACL and is therefore NOT the genesis of CC, rather a secretagogue for specific signature(s) that underlie the distinct crypt pathobiology of CC. Notably, we observed expansion of signatures after DEFA5 treatment on NCM460 and colonoids cells expressed at different times, intervals, and intensity. These factors are key stem cell niche regulators leading to DEFA5 secreting CCLCs differentiation 'the colonic ectopy ileal metaplasia formation' conspicuously of pathogenic importance in CC.
证据将细菌肠毒素与克罗恩病结肠炎(CC)患者结肠黏膜中的明显隐窝样细胞(CCLCs)和 Alpha 防御素 5(DEFA5)扩张联系起来。这些异位回肠化生区域,对 Paneth 细胞(PC)标志物呈阳性,与 CC 的诊断一致。回顾性地,我们:1. 在 2000-2007 年间确定了 21 名具有不确定结肠炎(IC)的患者,并在平均 8.7±3.7(范围,4-14)年后于 2014 年对其最终临床诊断进行了重新评估。他们的初始活检通过 DEFA5 生物测定进行了分析。2. 通过对 CC 患者的免疫组织化学(IHC)分析区分溃疡相关细胞谱系(UACL),用粘蛋白 6(MUC6)和 DEFA5 染色。3. 用纯 DEFA5 处理人永生化结肠上皮细胞(NCM460)和结肠类器官,24 小时后检测分泌物的特征。对照结肠类器官未进行处理。4. 用/不用肠毒素处理结肠类器官 14 天,并收集和测定 DEFA5、CCLCs 和其他生物学特征的表达量。该实验重复了两次。使用了三种统计方法:(i)单变量分析;(ii)LASSO;和(iii)弹性网络。DEFA5 生物测定法在具有 IC 患者的队列中以准确性区分 CC 和溃疡性结肠炎(UC)。拟合的逻辑模型将 CC 和 UC 作为结果组,将 DEFA5 作为独立变量,具有 96%的阳性预测值。CC 的 IHC 染色显示 MUC6 和 DEFA5 染色位于不同位置,表明 DEFA5 不在 UACL 中共同表达,因此不是 CC 的起源,而是特定特征的分泌剂,这些特征是 CC 独特隐窝病理生物学的基础。值得注意的是,我们观察到 NCM460 和结肠类器官细胞在不同时间、间隔和强度表达后,DEFA5 处理后的特征扩张。这些因素是关键的干细胞生态位调节剂,导致 DEFA5 分泌的 CCLCs 分化“结肠异位回肠化生形成”,在 CC 中具有明显的致病性重要性。